By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



111 Speen Street, Suite 306

Framingham  Massachusetts   01701  U.S.A.
Phone: 508-861-7709 Fax: n/a


Key Statistics

Ownership: Private

Web Site: Alzheon


Company News
Alzheon To Present At Upcoming Asian Healthcare And Scientific Conferences 10/4/2016 11:31:00 AM
Alzheon To Present At Upcoming Investor Conferences 9/21/2016 11:18:11 AM
Alzheon To Present At Upcoming Industry Conferences 9/7/2016 1:38:18 PM
Alzheon Presents Positive Results Of ALZ-801 Clinical Studies That Lead To Advancement To Pivotal Phase III Study In Alzheimer's Patients With APOE4/4 Homozygous Genotype 7/25/2016 10:47:33 AM
Alzheon To Present At The 2016 JMP Securities Life Sciences Conference 6/16/2016 10:19:10 AM
Alzheon Appoints Dennis H. Langer, MD, JD, To Board Of Directors 3/11/2016 10:09:52 AM
Alzheon Wants Another Shot at Alzheimer's, Presents Data for Tweaked Phase III Studies on Once-Rejected Drug Tramiprosate 3/11/2016 6:13:58 AM
Top 20 Life Science Startups to Watch in the U.S. 1/26/2016 7:46:23 AM
What You Need to Know About Alzheon 12/17/2015 11:27:21 AM
Alzheon Appoints Former GlaxoSmithKline (GSK) CEO Jean-Pierre Garnier As Chairman Of Board Of Directors 12/10/2015 10:36:27 AM